Class action deadlines near for shareholders of Lufax, Atara Biotherapeutics, and Coty over alleged misleading statements.

Class action lawsuits have been filed against Lufax Holding Ltd., Atara Biotherapeutics, and Coty Inc., alleging that these companies made false or misleading statements and failed to disclose material adverse facts affecting their business and financial prospects. Shareholders who suffered losses during the specified class periods are urged to file lead plaintiff motions by mid to late May 2026. These lawsuits claim issues such as misstated financial results for Lufax, manufacturing and regulatory problems for Atara, and underperformance and margin pressure for Coty. Investors interested in joining the class actions are advised to contact The Law Offices of Frank R. Cruz before the deadlines.